---
figid: PMC3339894__zeg0051288010002
figtitle: Putative molecular mechanisms of Wnt signaling, lipid metabolism, and IL-6
  effects on insulin signaling in nonobese PCOS adipose tissue
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3339894
filename: zeg0051288010002.jpg
figlink: /pmc/articles/PMC3339894/figure/F2/
number: F2
caption: Putative molecular mechanisms of Wnt signaling, lipid metabolism, and IL-6
  effects on insulin signaling in nonobese PCOS adipose tissue. Note that IL-6 signaling
  acts on both the phosphatidylinositol-3 kinase (PI3K) and the MAPK insulin signaling
  pathways (13) and that up-regulation of components of the MAPK pathway [P38, c-Jun-N-terminal
  kinase (JNK), and MAPK kinase (MEK)/ERK] further reduces insulin receptor substrate-1
  (IRS-1)/PI3K activity. Also, note that free fatty acids (FFA) activate protein kinase
  Cθ (PKCθ), which leads to inactivation of IRS-1 (17). Furthermore, up-regulation
  of one of the genes involved in lipid metabolism, DHRS9, increases MEK/ERK, which
  further reduces IRS-1/PI3K activity (15, 16). Note that inactivation of Wnt signaling
  stimulates glycogen synthase kinase-3β (GSK3β) in the active form, which may result
  in decreased glycogenesis and GLUT4 translocation, leading to insulin resistance
  (22). Our preliminary data indicate up or down regulation of key components of both
  the Wnt and insulin signaling pathways (see legend). Changes in RNA expression are
  indicated by green and red ovals. APC, Adenomatous polyposis coli; ATF, activating
  transcription factor 1; CKI, casein kinase I; DAG, dystroglycan 1; DKK, dickkopf-1;
  GRB2, growth factor receptor-bound protein 2, Groucho, transducin-like enhancer
  of split (E(sp1) homolog, Drosophila); GS, glycogen synthase; HDAC1, histone deacetylase
  1; JUN, jun proto-oncogene; LIPE, hormone-sensitive lipase; LRP, low density lipoprotein
  receptor-related protein 1; MYC, v-myc myelocytomatosis viral oncogene homolog (avian);
  NR5A2, nuclear receptor subfamily 5, group A, member 2; OCT4, octamer-binding transcription
  factor 4; PUFA, polyunsaturated fatty acid; sFRP, secreted Frizzled-related proteins;
  SHP2, protein tyrosine phosphatase, non-receptor type 11; SOX, SRY (sex determining
  region Y)-box.
papertitle: Abnormal Expression of Genes Involved in Inflammation, Lipid Metabolism,
  and Wnt Signaling in the Adipose Tissue of Polycystic Ovary Syndrome.
reftext: Gregorio Chazenbalk, et al. J Clin Endocrinol Metab. 2012 May;97(5):E765-E770.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9483821
figid_alias: PMC3339894__F2
figtype: Figure
redirect_from: /figures/PMC3339894__F2
ndex: 5690b155-deed-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3339894__zeg0051288010002.html
  '@type': Dataset
  description: Putative molecular mechanisms of Wnt signaling, lipid metabolism, and
    IL-6 effects on insulin signaling in nonobese PCOS adipose tissue. Note that IL-6
    signaling acts on both the phosphatidylinositol-3 kinase (PI3K) and the MAPK insulin
    signaling pathways (13) and that up-regulation of components of the MAPK pathway
    [P38, c-Jun-N-terminal kinase (JNK), and MAPK kinase (MEK)/ERK] further reduces
    insulin receptor substrate-1 (IRS-1)/PI3K activity. Also, note that free fatty
    acids (FFA) activate protein kinase Cθ (PKCθ), which leads to inactivation of
    IRS-1 (17). Furthermore, up-regulation of one of the genes involved in lipid metabolism,
    DHRS9, increases MEK/ERK, which further reduces IRS-1/PI3K activity (15, 16).
    Note that inactivation of Wnt signaling stimulates glycogen synthase kinase-3β
    (GSK3β) in the active form, which may result in decreased glycogenesis and GLUT4
    translocation, leading to insulin resistance (22). Our preliminary data indicate
    up or down regulation of key components of both the Wnt and insulin signaling
    pathways (see legend). Changes in RNA expression are indicated by green and red
    ovals. APC, Adenomatous polyposis coli; ATF, activating transcription factor 1;
    CKI, casein kinase I; DAG, dystroglycan 1; DKK, dickkopf-1; GRB2, growth factor
    receptor-bound protein 2, Groucho, transducin-like enhancer of split (E(sp1) homolog,
    Drosophila); GS, glycogen synthase; HDAC1, histone deacetylase 1; JUN, jun proto-oncogene;
    LIPE, hormone-sensitive lipase; LRP, low density lipoprotein receptor-related
    protein 1; MYC, v-myc myelocytomatosis viral oncogene homolog (avian); NR5A2,
    nuclear receptor subfamily 5, group A, member 2; OCT4, octamer-binding transcription
    factor 4; PUFA, polyunsaturated fatty acid; sFRP, secreted Frizzled-related proteins;
    SHP2, protein tyrosine phosphatase, non-receptor type 11; SOX, SRY (sex determining
    region Y)-box.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCL2L10
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - GSK3A
  - GSK3B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - PRKCI
  - IRS1
  - KRAS
  - HRAS
  - NRAS
  - MRSD
  - STAT3
  - TG
  - AXIN1
  - AXIN2
  - CSNK1E
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - APC
  - PROC
  - LIPE
  - PUM3
  - AKT1
  - AKT2
  - AKT3
  - CTNNB1
  - MUSK
  - RAPSN
  - FLAD1
  - SLC2A4
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - CD44
  - GDNF
  - PLAU
  - JUN
  - JUNB
  - JUND
  - arr
  - sgg
  - hop
  - bsk
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - inaC
  - Rst(2)At
  - ras
  - Ras64B
  - Ras85D
  - Tg
  - Axn
  - dco
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - SNF4Agamma
  - AMPKalpha
  - Apc
  - Apc2
  - Fs(3)Apc
  - Akt
  - arm
  - gro
  - Jra
  - Ser
  - Cancer
  - Diabetes mellitus
---
